KaloBios Fights Trustee As Shkreli's DC Showdown Nears
As former pharma executive Martin Shkreli prepares to face questions from Congress over alleged prescription drug price gouging, one of his former companies KaloBios Pharmaceuticals pushed back Tuesday in Delaware federal...To view the full article, register now.
Already a subscriber? Click here to view full article